The mammalian secreted RNases: Mechanisms of action in host defence

Innate Immunity

Volumn 19, Issue 1, 2013, Pages 86-97

  Gupta, Sandeep K ^a,b   Haigh, Brendan J ^a   Griffin, Frank J ^b   Wheeler, Thomas T ^a  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

angiogenin; antimicrobial; cytotoxins; mucosal immunity; RNase

Indexed keywords

ANGIOGENIN; BOVINE SEMINAL RIBONUCLEASE; EOSINOPHIL ASSOCIATED RIBONUCLEASE; RIBONUCLEASE; RIBONUCLEASE 3; RIBONUCLEASE 4; RIBONUCLEASE 7; RIBONUCLEASE 8; RIBONUCLEASE A; RIBONUCLEASE II; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; CYTOTOXICITY; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; MAMMAL; NONHUMAN; REVIEW;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; EOSINOPHILS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INFECTION; RIBONUCLEASE, PANCREATIC; SEMEN;

BOVINAE; MAMMALIA;

EID: 84872374733     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912446955     Document Type: Review

References (130)

1. Beintema JJ, Kleineidam RG. The ribonuclease A superfamily: general discussion. Cell Mol Life Sci. 1998 ; 54: 825-832
2. Salvatore S. The eight human "canonical" ribonucleases: Molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett. 2010 ; 584: 2194-2200
3. Cho S, Beintema J, Zhang J. The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics. 2005 ; 85: 208-220
4. Barnard E. Ribonucleases. Annu Rev Biochem. 1969 ; 38: 677-732
5. Harris P, Johannessen KM, Smolenski G, Callaghan M, Broadhurst MK, Kim K, et al. Characterisation of the anti-microbial activity of bovine milk ribonuclease4 and ribonuclease5 (angiogenin). Int Dairy J. 2010 ; 20: 400-407
6. Coulson E, Stevens H. Ribonuclease of bovine milk: Serological relationship to pancreatic ribonuclease. Arch Biochem Biophys. 1964 ; 107: 336-340
7. Preuss K, Wagner S, Freudenstein J, Scheit K. Cloning of cDNA encoding the complete precursor for bovine seminal ribonuclease. Nucleic Acids Res. 1990 ; 18: 1057-1057
8. D'Alessio G, Donato AD, Parente A, Piccoli R. Seminal RNase: a unique member of the ribonuclease superfamily. Trends Biochem Sci. 1991 ; 16: 104-106
9. Schmekel B, Ahlner J, Malmström M, Venge P. Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma. Respir Med. 2001 ; 95: 670-675
10. Robinovitch M, Sreebny L, Smuckler E. Ribonuclease and ribonuclease inhibitor of the rat parotid gland and its secretion. J Biol Chem. 1968 ; 243: 3441-3446
11. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy. 1995 ; 50: 610-613
12. Ackerman S, Loegering D, Venge P, Olsson I, Harley J, Fauci A, et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol. 1983 ; 131: 2977-2982
13. Cormier S, Larson K, Yuan S, Mitchell T, Lindenberger K, Carrigan P, et al. Mouse eosinophil-associated ribonucleases: a unique subfamily expressed during hematopoiesis. Mamm Genome. 2001 ; 12: 352-361
14. Durack D, Ackerman S, Loegering D, Gleich G. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci USA. 1981 ; 78: 5165-5169
15. Egesten A, Dyer K, Batten D, Domachowske J, Rosenberg H. Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro. BBA. 1997 ; 1358: 255-260
16. Cormier S, Yuan S, Crosby J, Protheroe C, Dimina D, Hines E, et al. T (H) 2-mediated pulmonary inflammation leads to the differential expression of ribonuclease genes by alveolar macrophages. Am J Respir Cell and Mol Biol. 2002 ; 27: 678-687
17. Zhao W, Confalone E, Breukelman H, Sasso M, Jekel P, Hodge E, et al. Ruminant brain ribonucleases: expression and evolution. BBA. 2001 ; 1547: 95-103
18. Toshiyuki O, Michio O, Minoru K, Takeshi K, Goro K. Purification, characterization and development of radioimmunoassay of human liver ribonuclease. Clin Chim Acta. 1982 ; 124: 51-62
19. Irie M, Nitta R, Ohgi K, Niwata Y, Watanabe H, Iwama M, et al. Primary structure of a non-secretory ribonuclease from bovine kidney. J Biochem. 1988 ; 104: 289-296
20. Spencer JD, Schwaderer AL, DiRosario JD, McHugh KM, McGillivary G, Justice SS, et al. Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int. 2011 ; 80: 174-180
21. Maeda T, Kitazoe M, Tada H, De Llorens R, Salomon DS, Ueda M, et al. Growth inhibition of mammalian cells by eosinophil cationic protein. Eur J Biochem. 2002 ; 269: 307-316
22. Lee JE, Raines RT. Cytotoxicity of bovine seminal ribonuclease: monomer versus dimer. Biochemistry. 2005 ; 44: 15760-15767
23. Ackerman S, Gleich G, Loegering D, Richardson B, Butterworth A. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg. 1985 ; 34: 735-745
24. Hamann K, Gleich G, Checkel J, Loegering D, McCall J, Barker R. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J Immunol. 1990 ; 144: 3166-3173
25. Hamann K, Barker R, Loegering D, Gleich G. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. J Parasitol. 1987 ; 73: 523-529
26. Lehrer R, Szklarek D, Barton A, Ganz T, Hamann K, Gleich G. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol. 1989 ; 142: 4428-4434
27. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol. 2003 ; 4: 269-273
28. Harder J, Schröder J. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem. 2002 ; 277: 46779-46784
29. Rudolph B, Podschun R, Sahly H, Schubert S, Schröder JM, Harder J. Identification of RNase 8 as a novel human antimicrobial protein. Antimicrob Agents Chemother. 2006 ; 50: 3194-3196
30. Garofalo R, Kimpen J, Welliver R, Ogra P. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr. 1992 ; 120: 28-32
31. Harrison A, Bonville C, Rosenberg H, Domachowske J. Respiratory syncytical virus-induced chemokine expression in the lower airways. Eosinophil recruitment and degranulation. Am J Respir Crit Care Med. 1999 ; 159: 1918-1924
32. Rugeles MT, Trubey CM, Bedoya VI, Pinto LA, Oppenheim JJ, Rybak SM, et al. Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS. 2003 ; 17: 481-486
33. Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res. 1998 ; 26: 3358-3363
34. Nei M, Gu X, Sitnikova T. Evolution by the birth-and-death process in multigene families of the vertebrate immune system. Proc Natl Acad Sci USA. 1997 ; 94: 7799-7806
35. Cadavid LF, Shufflebotham C, Ruiz FJ, Yeager M, Hughes AL, Watkins DI. Evolutionary instability of the major histocompatibility complex class I loci in New World primates. Proc Natl Acad Sci USA. 1997 ; 94: 14536-14541
36. Sitnikova T, Nei M. Evolution of immunoglobulin kappa chain variable region genes in vertebrates. Mol Biol Evol. 1998 ; 15: 50-60
37. Su C, Nei M. Evolutionary dynamics of the T-cell receptor VB gene family as inferred from the human and mouse genomic sequences. Mol Biol Evol. 2001 ; 18: 503-513
38. Rosenberg HF. RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol. 2008 ; 83: 1079-1087
39. Gordon M. Remarks on Hodgkin's disease: A Pathogenic agent in the glands, and its application in diagnosis. Br Med J. 1933 ; 1: 641-644
40. Durack DT, Sumi SM, Klebanoff SJ. Neurotoxicity of human eosinophils. Proc Natl Acad Sci USA. 1979 ; 76: 1443-1447
41. Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA. 1986 ; 83: 3146-3150
42. Slifman N, Loegering D, McKean D, Gleich G. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol. 1986 ; 137: 2913-2917
43. Rosenberg H. Eosinophil-derived neurotoxin/RNase 2: connecting the past, the present and the future. Curr Pharm Biotechnol. 2008 ; 9: 135-140
44. Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol. 2001 ; 70: 691-698
45. Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis. 1998 ; 177: 1458-1464
46. Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K, Oppenheim JJ. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood. 2003 ; 102: 3396-3403
47. Yang D, Chen Q, Rosenberg HF, Rybak SM, Newton DL, Wang ZY, et al. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol. 2004 ; 173: 6134-6142
48. Yang D, Chen Q, Su S, Zhang P, Kurosaka K, Caspi R, et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med. 2008 ; 205: 79-90
49. Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res. 2010 ; 343: 57-83
50. Rosenberg HF, Dyer KD, Tiffany HL, Gonzalez M. Rapid evolution of a unique family of primate ribonuclease genes. Nat Genet. 1995 ; 10: 219-223
51. Carreras E, Boix E, Rosenberg HF, Cuchillo CM, Nogués MV. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry. 2003 ; 42: 6636-6644
52. Boix E, Torrent M, Sanchez D, Nogues MV. The antipathogen activities of eosinophil cationic protein. Curr Pharm Biotechnol. 2008 ; 9: 141-152
53. Navarro S, Aleu J, Jiménez M, Boix E, Cuchillo C, Nogues M. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell Mol Life Sci. 2008 ; 65: 324-337
54. Wu CM, Chang MDT. Signal peptide of eosinophil cationic protein is toxic to cells lacking signal peptide peptidase. BBA. 2004 ; 322: 585-592
55. Chang HT, Kao YL, Wu CM, Fan T, Lai YK, Huang KL, et al. Signal peptide of eosinophil cationic protein upregulates transforming growth factor alpha expression in human cells. J Cell Biochem. 2007 ; 100: 1266-1275
56. Rosenberg HF. Recombinant human eosinophil cationic protein. J Biol Chem. 1995 ; 270: 7876-7881
57. Young JDE, Peterson CGB, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 1986 ; 321: 613-616
58. Torrent M, Cuyás E, Carreras E, Navarro S, López O, de la Maza A, et al. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Biochemistry. 2007 ; 46: 720-733
59. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogs with phospholipid membranes. Biochemistry. 1992 ; 31: 12416-12423
60. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J. 1999 ; 341: 501-513
61. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides. BBA. 2000 ; 1462: 55-70
62. Torrent M, Navarro S, Moussaoui M, Nogués MV, Boix E. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry. 2008 ; 47: 3544-3555
63. Mahmoud A, Warren KS, Peters PA. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med. 1975 ; 142: 805-813
64. Chang KC, Lo CW, Fan T, Chang MDT, Shu CW, Chang CH, et al. TNF-α Mediates eosinophil cationic protein-induced apoptosis in BEAS-2 B cells. BMC Cell Biol. 2010 ; 11: 6-6
65. Fan TC, Chang HT, Chen I. A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic. 2007 ; 8: 1778-1795
66. Fan T, Fang S, Hwang C, Hsu C, Lu X, Hung S, et al. Characterization of molecular interactions between eosinophil cationic protein and heparin. J Biol Chem. 2008 ; 283: 25468-25474
67. Venge P Allergy frontiers: diagnosis and health economics. Pawankar R Holgate ST Rosenwasser LJ, ed. Japan: Springer ; 2009: 453-471.
68. Vanto T, Koskinen P. Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy. 1998 ; 53: 415-419
69. Winterkamp S, Raithel M, Hahn EG. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. J Clin Gastroenterol. 2000 ; 30: 170-175
70. Park JW, Whang YW, Kim CW, Park YB, Hong CS. Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma. Allergy Asthma Proc. 1998 ;: 61-67
71. Venge P, Byström J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy. 1999 ; 29: 1172-1186
72. Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Adv Immunol. 1995 ; 60: 151-266
73. Kuwano K. Epithelial cell apoptosis and lung remodeling. Cell Mol Immunol. 2007 ; 4: 419-429
74. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008 ; 14: 949-953
75. Melo RCN, Spencer LA, Dvorak AM, Weller PF. Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. J Leukoc Biol. 2008 ; 83: 229-236
76. Straumann A, Simon HU. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy. 2004 ; 59: 15-25
77. Zhang J, Dyer KD, Rosenberg HF. Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. Proc Natl Acad Sci USA. 2000 ; 97: 4701-4706
78. Larson K, Olson E, Madden B, Gleich G, Lee N, Lee J. Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc Natl Acad Sci USA. 1996 ; 93: 12370-12375
79. Batten D, Dyer KD, Domachowske JB, Rosenberg HF. Molecular cloning of four novel murine ribonuclease genes: unusual expansion within the ribonuclease A gene family. Nucleic Acids Res. 1997 ; 25: 4235-4239
80. Singhania N, Dyer K, Zhang J, Deming M, Bonville C, Domachowske J, et al. Rapid evolution of the ribonuclease A superfamily: adaptive expansion of independent gene clusters in rats and mice. J Mol Evol. 1999 ; 49: 721-728
81. Ishihara K, Asai K, Nakajima M, Mue S, Ohuchi K. Preparation of recombinant rat eosinophil-associated ribonuclease-1 and -2 and analysis of their biological activities. BBA. 2003 ; 1638: 164-172
82. Moreau JM, Dyer KD, Bonville CA, Nitto T, Vasquez NL, Easton AJ, et al. Diminished expression of an antiviral ribonuclease in response to pneumovirus infection in vivo. Antiviral Res. 2003 ; 59: 181-191
83. Nitto T, Dyer K, Mejia R, Byström J, Wynn T, Rosenberg H. Characterization of the divergent eosinophil ribonuclease, mEar 6, and its expression in response to Schistosoma mansoni infection in vivo. Genes and Immun. 2004 ; 5: 668-674
84. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 1985 ; 24: 5480-5486
85. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry. 1986 ; 25: 3527-3532
86. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S, et al. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res. 2005 ; 65: 1352-1360
87. Lee HS, Lee I, Kang TC, Jeong GB, Chang SI. Angiogenin Is involved in morphological changes and angiogenesis in the ovary. BBA. 1999 ; 257: 182-186
88. King TV, Vallee BL. Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits. J Bone Joint Surg Br. 1991 ; 73: 587-590
89. Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA. Serum angiogenin in inflammatory bowel disease. Dig Dis Sci. 2004 ; 49: 1758-1762
90. Moenner M, Gusse M, Hatzi E, Badet J. The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur J Biochem. 1994 ; 226: 483-490
91. Olson KA, Verselis SJ, Fett JW. Angiogenin Is Regulatedin Vivoas an Acute Phase Protein. BBA. 1998 ; 242: 480-483
92. Avdeeva S, Chernukha M, Shaginyan I, Tarantul V, Naroditsky B. Human angiogenin lacks specific antimicrobial activity. Curr Microbiol. 2006 ; 53: 477-478
93. Tschesche H, Kopp C, Hörl W, Hempelmann U. Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment. J Biol Chem. 1994 ; 269: 30274-30280
94. Schmaldienst S, Oberpichler A, Tschesche H, Hörl WH. Angiogenin: A novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation. Kidney Blood Press Res. 2000 ; 26: 107-112
95. Kulka M, Fukuishi N, Metcalfe DD. Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily. J Leukoc Biol. 2009 ; 86: 1217-1226
96. Shcheglovitova O, Maksyanina E, Ionova I, Rustam'yan YL, Komolova G. Cow milk angiogenin induces cytokine production in human blood leukocytes. Bull Exp Biol Med. 2003 ; 135: 158-160
97. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011 ; 34: 637-650
98. Loo YM, Gale M. Immune signaling by RIG-I-like receptors. Immunity. 2011 ; 34: 680-692
99. Sharma S, Fitzgerald KA. Innate immune sensing of DNA. PLoS Pathog. 2011 ; 7: e1001310 - e1001310
100. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008 ; 205: 1601-1610
101. Zasloff M. Antimicrobial RNases of human skin. J Invest Dermatol. 2009 ; 129: 2091-2093
102. Abtin A, Eckhart L, Mildner M, Ghannadan M, Harder J, Schröder JM, et al. Degradation by stratum corneum proteases prevents endogenous RNase inhibitor from blocking antimicrobial activities of RNase 5 and RNase 7. J Invest Dermatol. 2009 ; 129: 2193-2201
103. Cho JS, Xuan C, Miller LS. Lucky number seven: RNase 7 can prevent Staphylococcus aureus skin colonization. J Invest Dermatol. 2010 ; 130: 2703-2706
104. Laudien M, Dressel S, Harder J, Gläser R. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology. 2011 ; 49: 107-111
105. Köten B, Simanski M, Gláser R, Podschun R, Schröder JM, Harder J. RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS One. 2009 ; 4: e6424 - e6424
106. Zhang J, Dyer KD, Rosenberg HF. Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res. 2003 ; 31: 602-607
107. Simanski M, Dressel S, Gläser R, Harder J. RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol. 2010 ; 130: 2836-2838
108. Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MDT, et al. The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem. 2007 ; 282: 4626-4633
109. Torrent M, Sánchez D, Buzón V, Nogués M, Cladera J, Boix E. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7. BBA. 2009 ; 1788: 1116-1125
110. Torrent M, Badia M, Moussaoui M, Sanchez D, Nogués M, Boix E. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall. FEBS J. 2010 ; 277: 1713-1725
111. Wiese A, Brandenburg K, Carroll SF, Rietschel ET, Seydel U. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Biochemistry. 1997 ; 36: 10311-10319
112. Lin YM, Wu SJ, Chang TW, Wang CF, Suen CS, Hwang MJ, et al. Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein. J Biol Chem. 2010 ; 285: 8985-8994
113. Wanke I, Steffen H, Christ C, Krismer B, Götz F, Peschel A, et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 2010 ; 131: 382-390
114. Mohammed I, Yeung A, Abedin A, Hopkinson A, Dua HS. Signalling pathways involved in ribonuclease-7 expression. Cell Mol Life Sci. 2010 ; 68: 1941-1952
115. Otri AM, Mohammed I, Abedin A, Cao Z, Hopkinson A, Panjwani N, et al. Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii: an in vitro study. Br J Ophthalmol. 2010 ; 94: 1523-1527
116. Reithmayer K, Meyer K, Kleditzsch P, Tiede S, Uppalapati S, Gläser R, et al. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol. 2009 ; 161: 78-89
117. Zhang J, Dyer KD, Rosenberg HF. RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucleic Acids Res. 2002 ; 30: 1169-1175
118. Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine. 2002 ; 81: 260-269
119. D'Alessio G. Evolution of oligomeric proteins. The unusual case of a dimeric ribonuclease. Eur J Biochem. 1999 ; 266: 699-708
120. Mastronicola MR, Piccoli R, D'Alessio G. Key extracellular and intracellular steps in the antitumor action of seminal ribonuclease. Eur J Biochem. 1995 ; 230: 242-249
121. Laccetti P, Spalletti-Cernia D, Portella G, De Corato P, D'Alessio G, Vecchio G. Seminal ribonuclease inhibits tumor growth and reduces the metastatic potential of Lewis lung carcinoma. Cancer Res. 1994 ; 54: 4253-4256
122. D'Errico G, Ercole C, Lista M, Pizzo E, Falanga A, Galdiero S, et al. Enforcing the positive charge of N-termini enhances membrane interaction and antitumor activity of bovine seminal ribonuclease. BBA. 2011 ; 1808: 3007-3015
123. Haigis MC, Raines RT. Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway. J Cell Sci. 2003 ; 116: 313-324
124. Kim JS, Soucek J, Matousek J, Raines RT. Mechanism of ribonuclease cytotoxicity. J Biol Chem. 1995 ; 270: 31097-31102
125. Spalletti-Cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, et al. Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis. J Clin Endocrinol Metab. 2003 ; 88: 2900-2907
126. Tamburrini M, Scala G, Verde C, Ruocco MR, Parente A, Venuta S, et al. Immunosuppressive activity of bovine seminal RNase on T-cell proliferation. Eur J Biochem. 1990 ; 190: 145-148
127. Soucek J, Marinov I, Benes J, Hilgert I, Matousek J, Raines RT. Immunosuppressive activity of bovine seminal ribonuclease and its mode of action. Immunobiology. 1996 ; 195: 271-285
128. Sinatra F, Callari D, Viola M, Longombardo M, Patania M, Litrico L, et al. Bovine seminal RNase induces apoptosis in normal proliferating lymphocytes. Int J Clin Lab Res. 2000 ; 30: 191-196
129. Cinatl J, Cinatl J, Kotchetkov R, Vogel J, Woodcock B, Matousek J, et al. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Int J Oncol. 1999 ; 15: 1001-1001
130. Hu CCA, Tang CHA, Wang JJ. Caspase activation in response to cytotoxic Rana catesbeiana ribonuclease in MCF-7 cells. FEBS Lett. 2001 ; 503: 65-68